Subscribe
Tuesday, September 15, 2026
21.6 C
Bengaluru
type here...
Subscribe
Ethics in Healthcare
8 min.Read

Sun Pharma: In the Eye of the Storm of Ophthalmologists

Anup Soans
By Anup Soans

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance, and the Regulatory Divide In July 2026, Sun Pharma recalled eleven eye care products after the All India Ophthalmological Society (AIOS) – a body of nearly 27,000 eye specialists – issued a patient safety alert about bacterial contamination consistent with pseudomonas species in certain batches of…

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

MedicinMan Pharma Pulse

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...
Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...

Topics

MedicinMan Pharma Pulse

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...
Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...
MedicinMan Pharma Pulse

MedicinMan Pharma Pulse: August 2026

0
🚀 The Mega-Merger That Wasn't Early August saw the...
Featured Article

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

0
STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...
Exclusive Report

How To See Dr Reddy’s Nestle In The Wellness Shift

0
GLP-1 medicines such as semaglutide and tirzepatide are changing...
spot_img

Related Articles

spot_imgspot_img
Previous article
Does India Need to Reinvent the Wheel on Junk Foods?
Next article
Mounjaro is the Exceptional Growth Story: Ranks #1

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

Medical Reps—Lessons From The West: The Old Model is Dead

0
The Core Conclusion The Western pharma industry is not simply...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk